Circadian variation of Rho-kinase activity in circulating leukocytes of patients with vasospastic angina

Circulation Journal

Volumn 78, Issue 5, 2014, Pages 1183-1190

  Nihei, Taro ^a   Takahashi, Jun ^a   Tsuburaya, Ryuji ^a   Ito, Yoshitaka ^a   Shiroto, Takashi ^a   Hao, Kiyotaka ^a   Takagi, Yusuke ^a   Matsumoto, Yasuharu ^a   Nakayama, Masaharu ^a   Miyata, Satoshi ^a   Sakata, Yasuhiko ^a   Ito, Kenta ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Circadian variation; Rho kinase activity; Vasospastic angina

Indexed keywords

ACETYLCHOLINE; NITRATE; RHO KINASE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD SAMPLING; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVITY; FEMALE; HEART RATE VARIABILITY; HEMODYNAMICS; HOLTER MONITORING; HUMAN; ISCHEMIC HEART DISEASE; LEUKOCYTE; MALE; MIDDLE AGED; PARASYMPATHETIC TONE; PROVOCATION TEST; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; VASOMOTOR REFLEX; VASOSPASTIC ANGINA;

EID: 84899625596     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1458     Document Type: Article

References (32)

1. Aschoff J. Circadian rhythms in man. Science 1965; 148: 1427-1432.
2. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989; 79: 733-743.
3. Maseri A, L'Abbate A, Baroldi G, Chierchia S, Marzilli M, Ballestra AM, et al. Coronary vasospasm as a possible cause of myocardial infarction: A conclusion derived from the study of "preinfarction" angina. New Engl J Med 1978; 299: 1271-1277.
4. Maseri A, Beltrame JF, Shimokawa H. Role of coronary vasoconstriction in ischemic heart disease and search for novel therapeutic targets. Circ J 2009; 73: 394-403.
5. JCS Joint Working Group. Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2008): Digest version. Circ J 2010; 74: 1745-1762.
6. Yasue H, Touyama M, Shimamoto M, Kato H, Tanaka S. Role of autonomic nervous system in the pathogenesis of Prinzmetal's variant form of angina. Circulation 1974; 50: 534-539.
7. Lanza GA, Pedrotti P, Pasceri V, Lucente M, Crea F, Maseri A. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol 1996; 28: 1249-1256.
8. Kawano H, Motoyama T, Yasue H, Hirai N, Waly HM, Kugiyama K, et al. Endothelial function fluctuates with diurnal variation in the frequency of ischemic episodes in patients with variant angina. J Am Coll Cardiol 2002; 40: 266-270.
9. Somlyo AP, Somlyo AV. Signal transduction and regulation in smooth muscle. Nature 1994; 372: 231-236.
10. Shimokawa H, Takeshita A. Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol 2005; 25: 1767-1775.
11. Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol 2007; 50: 17-24.
12. Shimokawa H, Seto M, Katsumata N, Amano M, Kozai T, Yamawaki T, et al. Rho-kinase-mediated pathway induces enhanced myosin light chain phosphorylations in a swine model of coronary artery spasm. Cardiovasc Res 1999; 43: 1029-1039.
13. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, et al. Inhibition of myosin phosphatase by upregulated Rhokinase plays a key role for coronary artery spasm in a porcine model with interleukin-1β. Circulation 2000; 101: 1319-1323.
14. Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M, Takeshita A. Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation 2002; 105: 1545-1547.
15. Kikuchi Y, Yasuda S, Aizawa K, Tsuburaya R, Ito Y, Takeda M, et al. Enhanced Rho-kinase activity in circulating neutrophils of patients with vasospastic angina: A possible biomarker for diagnosis and disease activity assessment. J Am Coll Cardiol 2011; 58: 1231-1237.
16. Nihei T, Takahashi J, Kikuchi Y, Takagi Y, Hao K, Tsuburaya R, et al. Enhanced Rho-kinase activity in patients with vasospastic angina after the Great East Japan Earthquake. Circ J 2012; 76: 2892-2894.
17. Doe Z, Fukumoto Y, Sugimura K, Miura Y, Tatebe S, Yamamoto S, et al. Rho-kinase activation in patients with heart failure. Circ J 2013; 77: 2542-2550.
18. Liu PY, Liao JK. A method for measuring Rho kinase activity in tissues and cells. Methods Enzymol 2008; 439: 181-189.
19. Shiroto T, Yasuda S, Tsuburaya R, Ito Y, Takahashi J, Ito K, et al. Role of Rho-kinase in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in pigs in vivo. J Am Coll Cardiol 2009; 54: 2321-2329.
20. Egashira K, Katsuda Y, Mohri M, Kuga T, Tagawa T, Shimokawa H, et al. Basal release of endothelium-derived nitric oxide at site of spasm in patients with variant angina. J Am Coll Cardiol 1996; 27: 1444-1449.
21. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-1065.
22. Yasue H, Omote S, Takizawa A, Nagao M, Miwa K, Tanaka S. Circadian variation of exercise capacity in patients with Prinzmetal's variant angina: Role of exercise-induced coronary arterial spasm. Circulation 1979; 59: 938-948.
23. Itoh T, Mizuno Y, Harada E, Yoshimura M, Ogawa H, Yasue H. Coronary spasm is associated with chronic low-grade inflammation. Circ J 2007; 71: 1074-1078.
24. Yasue H, Mizuno Y, Harada E, Itoh T, Nakagawa H, Nakayama M, et al. Effects of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium- channel blockers. J Am Coll Cardiol 2008; 51: 1742-1748.
25. Pepys MB, Hirschfield GM. C-reactive protein: A critical update. J Clin Invest 2003; 111: 1805-1812.
26. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, et al. Circadian variation in the frequency of onset of acute myocardial infarction. New Engl J Med 1985; 313: 1315-1322.
27. Dong M, Liao JK, Yan B, Li R, Zhang M, Yu CM. A combination of increased Rho kinase activity and N-terminal pro-B-type natriuretic peptide predicts worse cardiovascular outcome in patients with acute coronary syndrome. Int J Cardiol 2013; 167: 2813-2819.
28. Oi K, Shimokawa H, Hiroki J, Uwatoku T, Abe K, Matsumoto Y, et al. Remnant lipoproteins from patients with sudden cardiac death enhance coronary vasospastic activity through upregulation of Rhokinase. Arterioscler Thromb Vasc Biol 2004; 24: 918-922.
29. Feske SK, Sorond FA, Henderson GV, Seto M, Hitomi A, Kawasaki K, et al. Increased leukocyte ROCK activity in patients after acute ischemic stroke. Brain Res 2009; 1257: 89-93.
30. Okumura K, Yasue H, Matsuyama K, Goto K, Miyagi H, Ogawa H, et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. J Am Coll Cardiol 1988; 12: 883-888.
31. Takagi Y, Yasuda S, Takahashi J, Tsunoda R, Ogata Y, Seki A, et al. Clinical implications of provocation tests for coronary artery spasm: Safety, arrhythmic complications, and prognostic impact: Multicentre registry study of the Japanese Coronary Spasm Association. Eur Heart J 2013; 34: 258-267.
32. Sakata K, Iida K, Kudo M, Yoshida H, Doi O. Prognostic value of I-123 metaiodobenzylguanidine imaging in vasospastic angina without significant coronary stenosis. Circ J 2005; 69: 171-176.